TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
68 hedge funds and large institutions have $197M invested in Taro Pharmaceutical Industries Ltd. in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 27 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
19% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 27
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $15K
Holders
68
Holding in Top 10
1
Calls
–
Puts
$15K
Top Buyers
| 1 | +$3.34M | |
| 2 | +$1.83M | |
| 3 | +$1.63M | |
| 4 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.38M |
| 5 |
KAM
Krensavage Asset Management
New York
|
+$1.26M |
Top Sellers
| 1 | -$5.85M | |
| 2 | -$2.4M | |
| 3 | -$2.02M | |
| 4 |
Renaissance Technologies
New York
|
-$827K |
| 5 |
MGP
Metis Global Partners
San Diego,
California
|
-$766K |